NASDAQ:ABIO
Delisted

Arca Biopharma Stock Predictions

etoro logo Buy ABIO
*Your capital is at risk
$2.40
+0 (+0%)
At Close: Nov 29, 2024
Currently predicting for Fri, 5 Jun 2026

ABIO Prediction Chart

ABIO Predictions History

Latest community submissions for ABIO.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 4, 2024 $3.20 -1.58% $3.08 V 96.15% 1
Apr 4, 2024 Bullish $3.08 X 0
JS JS Pro
May 11, 2020 $4.04 +1.51% $3.98 X 98.49% 0
May 11, 2020 Bullish $3.98 X 0
JS JS Pro
Jun 27, 2019 $6.27 -11.32% $7.07 X 88.68% 0
JS JS Pro
May 17, 2019 $8.73 -7.23% $9.41 X 92.77% 0
JS JS Pro
May 8, 2019 $13.23 -12.38% $15.10 X 87.62% 0
May 8, 2019 $12.02 -20.40% $15.10 X 79.60% 0
joe1234 joe1234 Pro
May 8, 2019 $13.00 -13.91% $15.10 X 86.09% 0
May 8, 2019 $9.55 -36.75% $15.10 X 63.25% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABIO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ARCA BIOPHARMA
ARCA biopharma
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE